PPDI - Pharmaceutical Product Development Incorpo

$22.48 0.92 | 4.27%
Today's Range: 21.52 - 23.29
PPDI Avg. Daily Volume: 7,651,683
12/18/09 - 4:00 PM ET
TRADE NOW
Company Income Statement
Dec 2008 Dec 2007 Dec 2006 Dec 2005
Sales 1.57B 1.41B 1.25B 1.04B
Cost of Sales 817.70M 771.60M 670.53M 542.31M
Gross Operating Profit 752.20M 642.87M 577.16M 494.78M
Selling, General, and Administrative Expenses 399.11M 338.06M 302.54M 240.70M
Research & Development 9.23M 19.24M 5.41M 23.37M
Operating Income before D & A (EBITDA) 343.85M 285.57M 269.21M 230.71M
Depreciation & Amortization 60.43M 55.59M 47.74M 41.23M
Interest Income 16.66M 18.33M 15.07M 8.84M
Other Income - Net -19.10M 650.00K 927.00K -4.62M
Special Income / Charges -1.61M -690.00K -1.50M 5.14M
Total Income Before Interest Expenses (EBIT) 279.38M 248.27M 235.97M 198.84M
Interest Expense 537.00K 318.00K 469.00K 1.12M
Pre-Tax Income 278.84M 247.95M 235.50M 197.73M
Income Taxes 91.32M 84.55M 78.85M 66.25M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 187.52M 163.40M 156.65M 131.48M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 187.52M 163.40M 156.65M 131.48M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 187.52M 163.40M 156.65M 131.48M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
189.13M 164.09M 158.15M 126.34M
Preferred Dividends
Net Income Available To Common 187.52M 163.40M 156.65M 131.48M
Basic EPS from Continuing Ops. 1.58 1.38 1.34 1.15
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.58 1.38 1.34 1.15
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.58 1.38 1.34 1.15
Basic Normalized Net Income/Share 1.59 1.39 1.35 1.11
EPS fr Continuing Ops. 1.56 1.36 1.32 1.13
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.56 1.36 1.32 1.13
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.56 1.36 1.32 1.13
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.57 1.37 1.33 1.09
Dividends Paid per Share 0.43 0.19 0.11 0.53
Latest PPDI Headlines

Brokerage Partners

TheStreet Premium Services

All Services